HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy of continuous intravenous drip infusion of disopyramide in hypertrophic obstructive cardiomyopathy during cardiogenic shock: a case report].

Abstract
A 54-year-old woman was admitted to our hospital complaining of dyspnea due to hypertrophic obstructive cardiomyopathy. On admission, she was treated with 4 antiarrhythmic drugs and 2 beta-blockers. After 4 of these 6 drugs were withdrawn, the left ventricular outflow pressure gradient markedly increased and then she fell into cardiogenic shock. Therefore, disopyramide(600 mg/day) was administered by continuous intravenous drip infusion to reduce the left ventricular outflow pressure gradient. After intravenous administration of disopyramide, the left ventricular outflow pressure gradient markedly decreased from 100 to 16 mmHg and the cardiogenic shock could be improved. Continuous intravenous drip infusion of disopyramide is effective for the treatment of cardiogenic shock due to severe left ventricular outflow obstruction in patients with hypertrophic obstructive cardiomyopathy.
AuthorsK Kajimoto, T Harada, K Imamura, N Matsuda, K Niki, N Hagiwara, H Kasanuki
JournalJournal of cardiology (J Cardiol) Vol. 35 Issue 3 Pg. 197-203 (Mar 2000) ISSN: 0914-5087 [Print] Netherlands
PMID10808427 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Disopyramide
Topics
  • Anti-Arrhythmia Agents (administration & dosage)
  • Cardiomyopathy, Hypertrophic (complications, drug therapy)
  • Disopyramide (administration & dosage)
  • Female
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Shock, Cardiogenic (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: